Celon Pharma SA (CLN) — Cash Flow-to-Debt Ratio
Celon Pharma SA (CLN) has a Cash Flow-to-Debt Ratio of -0.03x as of March 2026, meaning its operating cash flow of zł-4.79 Million could theoretically repay 0% of its total liabilities (zł141.95 Million) in one year. See Celon Pharma SA free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Celon Pharma SA Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Celon Pharma SA across 14 annual periods. For the full cash flow conversion analysis, see Celon Pharma SA cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Celon Pharma SA (2012–2025)
Year-by-year debt coverage analysis for Celon Pharma SA. Check CLN cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (PLN) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.32x | zł23.86 Million | zł74.47 Million | ▲ +378.6% |
| 2024 | -0.12x | zł-11.34 Million | zł98.59 Million | ▼ -71.2% |
| 2023 | -0.07x | zł-8.31 Million | zł123.75 Million | ▼ -84.8% |
| 2022 | -0.04x | zł-4.70 Million | zł129.29 Million | ▼ -112.7% |
| 2021 | 0.29x | zł43.95 Million | zł153.14 Million | ▲ +8.9% |
| 2020 | 0.26x | zł70.90 Million | zł268.97 Million | ▲ +863.6% |
| 2019 | -0.03x | zł-5.05 Million | zł146.31 Million | ▼ -114.1% |
| 2018 | 0.25x | zł28.24 Million | zł114.94 Million | ▼ -17.3% |
| 2017 | 0.30x | zł25.30 Million | zł85.20 Million | ▼ -11.1% |
| 2016 | 0.33x | zł20.65 Million | zł61.82 Million | ▼ -57.0% |
| 2015 | 0.78x | zł52.37 Million | zł67.47 Million | ▲ +14.1% |
| 2014 | 0.68x | zł24.36 Million | zł35.82 Million | ▲ +144.6% |
| 2013 | 0.28x | zł8.45 Million | zł30.39 Million | ▼ -69.3% |
| 2012 | 0.90x | zł12.87 Million | zł14.22 Million | — |